Trials / Suspended
SuspendedNCT00465257
Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar
Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction as New Treatment Policy for Uncomplicated Plasmodium Falciparum Malaria in Zanzibar
- Status
- Suspended
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Months – 59 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy of artesuante + amodiaquine four years after its introduction as first line treatment for uncomplicated childhood malaria in Zanzibar. The hypothesis is that the treatment has a polymerase chain reaction (PCR)adjusted parasitological cure rate of at least 85% 42 days after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | artesunate + amodiaquine |
Timeline
- Start date
- 2007-05-01
- First posted
- 2007-04-24
- Last updated
- 2008-05-20
Locations
1 site across 1 country: Tanzania
Source: ClinicalTrials.gov record NCT00465257. Inclusion in this directory is not an endorsement.